VOI - Voice of Indonesia | RRI - Radio Republik Indonesia

photo : msn.com

Indonesia will follow the World Health Organization’s lead, in suspending the use of hydroxychloroquine for COVID-19 treatment, as part of the global Solidarity Trials, according to the COVID-19 task force. Team leader of the Task Force for the Acceleration of COVID-19 Handling, Wiku Adisasmito, said during a press conference on Thursday in Jakarta as quoted by Antara. Wiku confirmed the WHO has temporarily halted Solidarity Trials of hydroxychloroquine, and said it will provide the results of its final assessment regarding the use of the malaria drug for COVID-19 treatment in two weeks. More than 30 countries are participating in the Solidarity Trial, a WHO initiative for joint research and clinical testing to develop drugs and therapies for COVID-19 treatment. The Solidarity Trial will compare standard treatment against treatment using four types of drugs, namely remdesivir, liponavir / ritonavir, liponavir / ritonavir combined with beta-1 interferon, and chloroquine//ANT